ADJUVANT CHEMOTHERAPY IN RESECTED NSCLC: TREATMENT FACTORS THAT IMPACT SURVIVAL OUTCOMES

被引:0
|
作者
Ramsden, K. [1 ]
Laskin, J. [1 ]
Ho, C. [1 ]
机构
[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
76P
引用
收藏
页码:S31 / S32
页数:2
相关论文
共 50 条
  • [1] ESTIMATING SURVIVAL AFTER ADJUVANT CHEMOTHERAPY FOR RESECTED NSCLC
    McCaughan, G.
    Blinman, P.
    Boyer, M.
    Stockler, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) : S31 - S31
  • [2] Effectiveness of adjuvant chemotherapy for resected NSCLC
    Stuschke, Martin
    Poettgen, Christoph
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (11) : 613 - 614
  • [3] Effectiveness of adjuvant chemotherapy for resected NSCLC
    Martin Stuschke
    Christoph Pöttgen
    [J]. Nature Reviews Clinical Oncology, 2010, 7 : 613 - 614
  • [4] Timing of Adjuvant Chemotherapy and Impact on Survival for Resected Gastric Cancer
    Erin K. Greenleaf
    Afif N. Kulaylat
    Christopher S. Hollenbeak
    Khaldoun Almhanna
    Joyce Wong
    [J]. Annals of Surgical Oncology, 2016, 23 : 4203 - 4213
  • [5] Timing of Adjuvant Chemotherapy and Impact on Survival for Resected Gastric Cancer
    Greenleaf, Erin K.
    Kulaylat, Afif N.
    Hollenbeak, Christopher S.
    Almhanna, Khaldoun
    Wong, Joyce
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (13) : 4203 - 4213
  • [6] Survival outcomes in GBM: The impact of adjuvant chemotherapy
    Blumenthal, DT
    Bokstein, F
    Conlee, JW
    Batten, JA
    Jensen, RL
    McNeill, KL
    Jacques, E
    Baram, J
    Ram, Z
    [J]. NEURO-ONCOLOGY, 2004, 6 (04) : 370 - 370
  • [7] Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma
    Nedim Turan
    Mustafa Benekli
    Olcun Umit Unal
    ?lkay Tugba Unek
    Didem Tastekin
    Faysal Dane
    Efnan Alg?n
    Sukran Ulger
    Tulay Eren
    Turkan Ozturk Topcu
    Esma Turkmen
    Nalan Akgül Babacan
    Gulnihal Tufan
    Zuhat Urakci
    Basak Oven Ustaalioglu
    Ozlem Sonmez Uysal
    Ozlem Balvan Ercelep
    Burcu Yapar Taskoylu
    Asude Aksoy
    Mustafa Canhoroz
    Umut Demirci
    Erkan Dogan
    Veli Berk
    Ozan Balakan
    Ahmet ?iyar Ekinci
    Mukremin Uysal
    ?brahim Petekkaya
    Sel?uk Cemil Ozturk
    ?nder Tonyal?
    Bülent ?etin
    Mehmet Naci Aldemir
    Kaan Helvac?
    Nuriye Ozdemir
    ?lhan Oztop
    Ugur Coskun
    Aytug Uner
    Ahmet Ozet
    Suleyman Buyukberber
    [J]. Chinese Journal of Cancer Research, 2015, 27 (04) : 408 - 416
  • [8] Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma
    Turan, Nedim
    Benekli, Mustafa
    Unal, Olcun Umit
    Unek, Ilkay Tugba
    Tastekin, Didem
    Dane, Faysal
    Algin, Efnan
    Ulger, Sukran
    Eren, Tulay
    Topcu, Turkan Ozturk
    Turkmen, Esma
    Babacan, Nalan Akgul
    Tufan, Gulnihal
    Urakci, Zuhat
    Ustaalioglu, Basak Oven
    Uysal, Ozlem Sonmez
    Ercelep, Ozlem Balvan
    Taskoylu, Burcu Yapar
    Aksoy, Asude
    Canhoroz, Mustafa
    Demirci, Umut
    Dogan, Erkan
    Berk, Veli
    Balakan, Ozan
    Ekinci, Ahmet Siyar
    Uysal, Mukremin
    Petekkaya, Ibrahim
    Ozturk, Selcuk Cemil
    Tonyali, Onder
    Cetin, Bulent
    Aldemir, Mehmet Naci
    Helvaci, Kaan
    Ozdemir, Nuriye
    Oztop, Ilhan
    Coskun, Ugur
    Uner, Aytug
    Ozet, Ahmet
    Buyukberber, Suleyman
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2015, 27 (04) : 408 - 416
  • [9] Survival data of postoperative adjuvant chemotherapy of cisplatin plus vinorelbine for completely resected NSCLC
    Kenmotsu, Hirotsugu
    Ohde, Yasuhisa
    Wakuda, Kazushige
    Nakashima, Kazuhisa
    Omori, Shota
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Endo, Masahiro
    Takahashi, Toshiaki
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [10] Timing of adjuvant chemotherapy and impact on survival for resected gastric cancer.
    Greenleaf, Erin
    Hollenbeak, Christopher S.
    Wong, Joyce
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)